On June 1, 2021, CTI Biopharma announced that the U.S. Food and Drug Administration has accepted its New Drug Application (NDA) for pacritinib, an oral kinase inhibitor in the pipeline, to treat myelofibrosis, a disease associated with severe thrombocytopenia. The FDA also granted priority review st......

The inactivated Coronavirus vaccine independently developed by the Institute of Medical Biology, Chinese Academy of Medical Sciences (hereinafter referred to as the Institute of Biology, Chinese Academy of Medical Sciences) is the first batch of Coronavirus inactivated vaccine marketed for emergency......

Multiple clinical trials and real-world studies have shown that the COVID-19 vaccine provides effective protection against COVID-19 in recipients. The other goal of mass vaccination is "herd immunity," which means that when a sufficient percentage of the population becomes immune from the vaccine (o......

Researchers have found that an antibiotic known as novobiocin (NVB), discovered in the 1950s, is effective in killing tumor cells that carry defects in homologous recombinant (HR) DNA repair. This ability to kill is also effective against tumor cells that have acquired resistance to the poly (ADP) r......

In collaboration with the Center for Predictive Medicine at the University of Louisville, opaganib was studied in a 3D human bronchial cortical cell (Epioriginal ™) tissue model to evaluate its efficacy against the SARS-CoV-2 variants of β (South Africa) and γ (Brazil) in vitro. Preliminary results ......

Recently, a team from Cardiff University published a study titled Aspirin and Cancer Survival: A systematic review and meta-analysis of 118 observational studies of Aspirin and 18 cancers, The study found that taking aspirin as part of treatment for many types of cancer could reduce the risk of deat......